Obesity and liver cancer risk: An evaluation based on a systematic review of epidemiologic evidence among the Japanese population

Japanese Journal of Clinical Oncology

Volumn 42, Issue 3, 2012, Pages 212-221

  Tanaka, Keitaro ^a   Tsuji, Ichiro ^b   Tamakoshi, Akiko ^c   Matsuo, Keitaro ^d   Ito, Hidemi ^d   Wakai, Kenji ^e   Nagata, Chisato ^f   Mizoue, Tetsuya ^g   Sasazuki, Shizuka ^h   Inoue, Manami ^h   Tsugane, Shoichiro ^h   Iwasaki, Motoki ^h   Otani, Tetsuya ^h   Sawada, Norie ^h   Shimazu, Taichi ^h   Tsubono, Yoshitaka ^b   Nishino, Yoshikazu ⁱ  

^a SAGA UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d AICHI CANCER CENTER HOSPITAL   (Japan)

^e NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^h NATIONAL CANCER CENTER   (Japan)

ⁱ MIYAGI CANCER CENTER RESEARCH INSTITUTE   (Japan)

Author keywords

Epidemiology; Japanese; Liver cancer; Obesity; Systematic review

Indexed keywords

ALCOHOL LIVER CIRRHOSIS; ARTICLE; BODY MASS; CANCER RISK; CHRONIC LIVER DISEASE; HEPATITIS B; HEPATITIS C; HUMAN; JAPANESE; LIFESTYLE; LIVER CANCER; MEDLINE; OBESITY; SYSTEMATIC REVIEW (TOPIC);

ASIAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; JAPAN; LIVER NEOPLASMS; MALE; OBESITY; RISK FACTORS;

EID: 84863230668     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hyr198     Document Type: Article

References (43)

1. International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 59. Hepatitis Viruses. Lyon, France: IARC 1994.
2. World Cancer Research Fund, American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington, DC: AICR 2007.
3. Tanaka K, Tsuji I, Wakai K, Nagata C, Mizoue T, Inoue M, et al. Alcohol drinking and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among the Japanese population. Jpn J Clin Oncol 2008;38:816-38.
4. International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 96. Consumption of Alcoholic Beverages and Ethyl Carbamate (Urethane). Lyon, France: IARC 2010.
5. Ikai I, Arii S, Okazaki M, Okita K, Omata M, Kojiro M, et al. Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol Res 2007;37:676-91.
6. Bugianesi E, Leone N, Vanni E, Marchesini G, Brunello F, Carucci P, et al. Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002;123:134-40.
7. Shimada M, Hashimoto E, Taniai M, Hasegawa K, Okuda H, Hayashi N, et al. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. J Hepatol 2002;37:154-60.
8. Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 2010;51:1820-32.
9. Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 2006;43:S99-112.
10. Nair S, Mason A, Eason J, Loss G, Perrillo RP. Is obesity an independent risk factor for hepatocellular carcinoma in cirrhosis? Hepatology 2002;36:150-5.
11. Ohki T, Tateishi R, Sato T, Masuzaki R, Imamura J, Goto T, et al. Obesity is an independent risk factor for hepatocellular carcinoma development in chronic hepatitis C patients. Clin Gastroenterol Hepatol 2008;6:459-64.
12. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625-38.
13. Oh SW, Yoon YS, Shin SA. Effects of excess weight on cancer incidences depending on cancer sites and histologic findings among men: Korea National Health Insurance Corporation Study. J Clin Oncol 2005;23:4742-54.
14. Larsson SC, Wolk A. Overweight, obesity and risk of liver cancer: a meta-analysis of cohort studies. Br J Cancer 2007;97:1005-8.
15. Saunders D, Seidel D, Allison M, Lyratzopoulos G. Systematic review: the association between obesity and hepatocellular carcinoma- epidemiological evidence. Aliment Pharmacol Ther 2010;31:1051-63.
16. Tanaka K, Ikematsu H, Hirohata T, Kashiwagi S. Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: possible role of type 1b (II) infection. J Natl Cancer Inst 1996;88:742-6.
17. Inoue M, Tsuji I, Wakai K, Nagata C, Mizoue T, Tanaka K, et al. Evaluation based on systematic review of epidemiological evidence among Japanese populations: tobacco smoking and total cancer risk. Jpn J Clin Oncol 2005;35:404-11.
18. World Health Organization. WHO Technical Reports Series 916. Diet, Nutrition and the Prevention of Chronic Diseases: Report of a Joint WHO/FAO Expert Consultation. Geneva: WHO 2003.
19. Tsugane S, Sobue T. Baseline survey of JPHC study-design and participation rate. Japan Public Health Center-based Prospective Study on Cancer and Cardiovascular Diseases. J Epidemiol 2001;11:S24-9.
20. Egger M, Smith GD, Altman DG, editors. Systematic Reviews in Health Care: Meta-Analysis in Context. London: BMJ Publishing Group 2001.
21. Sutton AJ, Abrams KR, Jones DR, Sheldon TA, Song F. Methods for Meta-Analysis in Medical Research. Chichester, England: John Wiley & Sons Ltd 2000.
22. Ohata K, Hamasaki K, Toriyama K, Matsumoto K, Saeki A, Yanagi K, et al. Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection. Cancer 2003;97:3036-43.
23. Kuriyama S, Tsubono Y, Hozawa A, Shimazu T, Suzuki Y, Koizumi Y, et al. Obesity and risk of cancer in Japan. Int J Cancer 2005;113:148-57.
24. Khan MM, Saito S, Takagi S, Ohnishi H, Izumi H, Sakauchi F, et al. Relationship between hepatocellular carcinoma and impaired glucose tolerance among Japanese. Hepatogastroenterology 2006;53:742-6.
25. Muto Y, Sato S, Watanabe A, Moriwaki H, Suzuki K, Kato A, et al. Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and long-term oral supplementation with branched-chain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis. Hepatol Res 2006;35:204-14.
26. Fujino Y. Anthropometry, development history and mortality in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC). Asian Pac J Cancer Prev 2007;8(Suppl):105-12.
27. Inoue M, Kurahashi N, Iwasaki M, Tanaka Y, Mizokami M, Noda M, et al. Metabolic factors and subsequent risk of hepatocellular carcinoma by hepatitis virus infection status: a large-scale population-based cohort study of Japanese men and women (JPHC Study Cohort II). Cancer Causes Control 2009;20:741-50.
28. Kurosaki M, Hosokawa T, Matsunaga K, Hirayama I, Tanaka T, Sato M, et al. Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy. Hepatol Res 2010;40:870-7.
29. Bekku D, Arai M, Imazeki F, Yonemitsu Y, Kanda T, Fujiwara K, et al. Long-term follow-up of patients with hepatitis B e antigen negative chronic hepatitis B. J Gastroenterol Hepatol 2011;26:122-8.
30. Kabutake A, Tokushige K, Tobari M, Yatsuji S, Taniai M, Haruta I, et al. Transition of hepatocellular carcinoma associated with alcoholic liver disease in our hospital. Igaku-to-Yakugaku 2007;58:706-9 (in Japanese).
31. Ohishi W, Fujiwara S, Cologne JB, Suzuki G, Akahoshi M, Nishi N, et al. Risk factors for hepatocellular carcinoma in a Japanese population: a nested case-control study. Cancer Epidemiol Biomarkers Prev 2008;17:846-54.
32. Horie Y, Yamagishi Y, Ebinuma H, Hibi T. Characteristic of hepatocellular carcinoma in alcoholic liver cirrhosis in Japan. Kanzo 2011;52:70-3 (in Japanese).
33. International Agency for Research on Cancer. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 83. Tobacco Smoke and Involuntary Smoking. Lyon, France: IARC 2004.
34. Tanaka K, Tsuji I, Wakai K, Nagata C, Mizoue T, Inoue M, et al. Cigarette smoking and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among Japanese. Jpn J Clin Oncol 2006;36:445-56.
35. Hara M, Tanaka K, Sakamoto T, Higaki Y, Mizuta T, Eguchi Y, et al. Case-control study on cigarette smoking and the risk of hepatocellular carcinoma among Japanese. Cancer Sci 2008;99:93-7.
36. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004;4:579-91.
37. Lefkowitch JH, Schiff ER, Davis GL, Perrillo RP, Lindsay K, Bodenheimer HC, Jr, et al. Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group. Gastroenterology 1993;104:595-603.
38. Pekow JR, Bhan AK, Zheng H, Chung RT. Hepatic steatosis is associated with increased frequency of hepatocellular carcinoma in patients with hepatitis C-related cirrhosis. Cancer 2007;109:2490-6.
39. Bugianesi E, McCullough AJ, Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 2005;42:987-1000.
40. Ish-Shalom D, Christoffersen CT, Vorwerk P, Sacerdoti-Sierra N, Shymko RM, Naor D, et al. Mitogenic properties of insulin and insulin analogues mediated by the insulin receptor. Diabetologia 1997;40(Suppl 2):S25-31.
41. Yang S, Zhu H, Li Y, Lin H, Gabrielson K, Trush MA, et al. Mitochondrial adaptations to obesity-related oxidant stress. Arch Biochem Biophys 2000;378:259-68.
42. Yang S, Lin HZ, Hwang J, Chacko VP, Diehl AM. Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? Cancer Res 2001;61:5016-23.
43. Moriya K, Nakagawa K, Santa T, Shintani Y, Fujie H, Miyoshi H, et al. Oxidative stress in the absence of inflammation in a mouse model for hepatitis C virus-associated hepatocarcinogenesis. Cancer Res 2001;61:4365-70.